
Ceftrinject S 500mg/250mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftrinject S 500mg/250mg Injection
Combiflox 500mg/250mg injection combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare professional, this dual-action medication requires adherence to the prescribed treatment schedule. Complete the full course, even with symptom improvement, to ensure efficacy. Premature cessation may reduce effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration facilitate recovery. Your doctor might order lab tests to monitor treatment response.
Primary Ingredients of Ceftrinject S 500mg/250mg Injection
No information provided. A rephrased version cannot be created.
Uses of Ceftrinject S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftrinject S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; please do not self-medicate.
Common Side effects of Ceftrinject S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftrinject S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Ceftrinject S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftrinject S 500mg/250mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing enzymes that bacteria use to resist antibiotic effects, thereby bolstering Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ceftrinject S 500mg/250mg Injection shows no adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
Ceftrinject S 500mg/250mg injections are typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftrinject S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftrinject S 500mg/250mg Injection may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftrinject S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The use of Ceftrinject S 500mg/250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Ceftrinject S 500mg/250mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceftrinject S 500mg/250mg Injection :
Omit a dose of Ceftrinject S 500mg/250mg Injection? Seek medical advice immediately.
Facts to Know About Ceftrinject S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
